Physical activity and longitudinal change in 6-min walk distance in COPD patients

Summary Background The 6-min walk distance (6MWD) is widely used to evaluate functional capacity in patients with chronic obstructive pulmonary disease (COPD). Aim To examine predictors for longitudinal change in 6MWD including self-reported physical activity, smoking habits, body composition, exace...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2014-01, Vol.108 (1), p.86-94
Hauptverfasser: Frisk, Bente, Espehaug, Birgitte, Hardie, Jon A, Strand, Liv I, Moe-Nilssen, Rolf, Eagan, Tomas M.L, Bakke, Per S, Thorsen, Einar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 94
container_issue 1
container_start_page 86
container_title Respiratory medicine
container_volume 108
creator Frisk, Bente
Espehaug, Birgitte
Hardie, Jon A
Strand, Liv I
Moe-Nilssen, Rolf
Eagan, Tomas M.L
Bakke, Per S
Thorsen, Einar
description Summary Background The 6-min walk distance (6MWD) is widely used to evaluate functional capacity in patients with chronic obstructive pulmonary disease (COPD). Aim To examine predictors for longitudinal change in 6MWD including self-reported physical activity, smoking habits, body composition, exacerbations, comorbidity and lung function. Methods The cohort included 389 patients aged 44–75 years, with clinically stable COPD in GOLD stages II–IV. The follow-up time was 3 years. Measurements included 6MWD, spirometry, fat and fat free mass index (FMI and FFMI), and assessment of physical activity, smoking habits, comorbidities and exacerbations by questionnaires. Generalized estimating equations (GEE) regression analyses were used to analyze predictors for the change in 6MWD. Results There was a reduction in 6MWD from baseline to 3 years for patients in GOLD stages III and IV ( B  = −36 m, 95% CI = −51 to −7, p  = 0.009 and B  = −79 m, CI = −125 to −20, p  = 0.007). The unadjusted GEE analysis demonstrated that baseline self-reported physical activity level, forced expiratory volume in one second (FEV1 ), forced vital capacity, FFMI, GOLD stages and age predicted change in 6MWD, but in the adjusted GEE analysis only self-reported physical activity level ( p  = 0.001) and FEV1 ( p  = 0.019) predicted change over time. Conclusion Patients in GOLD stage II maintained their functional capacity assessed by 6MWD over 3 years, while it was significantly reduced for patients in GOLD stages III and IV. Level of physical activity and FEV1 were predictors for longitudinal change in functional capacity.
doi_str_mv 10.1016/j.rmed.2013.09.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1881754758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0954611113003697</els_id><sourcerecordid>1881754758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c615t-1b7040b9578f142a4df87c14c6526a15e332b7bfbd9410ff002d105fb8b755b23</originalsourceid><addsrcrecordid>eNqFks1q3DAUhUVpaaZpX6CLYuimG7v36teGUijTXwgk9GctZFlONPHIU8lOmbfps_TJKmcSClk0K8G93zmgcy4hzxEqBJSvN1Xcuq6igKyCpgLgD8gKBaMlA8kfkhU0gpcSEY_Ik5Q2ANBwDo_JEeWgBAOxIl_PLvbJWzMUxk7-yk_7woSuGMZw7qe58yFv7IUJ567woZDl1oc_v3-Z4bLofJpMsNfz9enZ-2JnJu_ClJ6SR70Zknt28x6THx8_fF9_Lk9OP31ZvzsprUQxldgq4NA2QtU9cmp419fKIrdSUGlQOMZoq9q-7RqO0PcAtEMQfVu3SoiWsmPy6uC7i-PP2aVJb32ybhhMcOOcNNY1KsGVqO9HBXJOQQp2P8obqkBl74y-vINuxjnmxK4pZBwlE5miB8rGMaXoer2LfmviXiPopUe90UuPeulRQ6Nzj1n04sZ6bpfdreS2uAy8OQAuJ3zlXdTJ5vSt63x0dtLd6P_v__aO3A4-LHdw6fYu_fuHTlSD_rZc0nJIyACYbBT7CymVwLs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1491341635</pqid></control><display><type>article</type><title>Physical activity and longitudinal change in 6-min walk distance in COPD patients</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via ScienceDirect (Elsevier)</source><creator>Frisk, Bente ; Espehaug, Birgitte ; Hardie, Jon A ; Strand, Liv I ; Moe-Nilssen, Rolf ; Eagan, Tomas M.L ; Bakke, Per S ; Thorsen, Einar</creator><creatorcontrib>Frisk, Bente ; Espehaug, Birgitte ; Hardie, Jon A ; Strand, Liv I ; Moe-Nilssen, Rolf ; Eagan, Tomas M.L ; Bakke, Per S ; Thorsen, Einar</creatorcontrib><description>Summary Background The 6-min walk distance (6MWD) is widely used to evaluate functional capacity in patients with chronic obstructive pulmonary disease (COPD). Aim To examine predictors for longitudinal change in 6MWD including self-reported physical activity, smoking habits, body composition, exacerbations, comorbidity and lung function. Methods The cohort included 389 patients aged 44–75 years, with clinically stable COPD in GOLD stages II–IV. The follow-up time was 3 years. Measurements included 6MWD, spirometry, fat and fat free mass index (FMI and FFMI), and assessment of physical activity, smoking habits, comorbidities and exacerbations by questionnaires. Generalized estimating equations (GEE) regression analyses were used to analyze predictors for the change in 6MWD. Results There was a reduction in 6MWD from baseline to 3 years for patients in GOLD stages III and IV ( B  = −36 m, 95% CI = −51 to −7, p  = 0.009 and B  = −79 m, CI = −125 to −20, p  = 0.007). The unadjusted GEE analysis demonstrated that baseline self-reported physical activity level, forced expiratory volume in one second (FEV1 ), forced vital capacity, FFMI, GOLD stages and age predicted change in 6MWD, but in the adjusted GEE analysis only self-reported physical activity level ( p  = 0.001) and FEV1 ( p  = 0.019) predicted change over time. Conclusion Patients in GOLD stage II maintained their functional capacity assessed by 6MWD over 3 years, while it was significantly reduced for patients in GOLD stages III and IV. Level of physical activity and FEV1 were predictors for longitudinal change in functional capacity.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2013.09.004</identifier><identifier>PMID: 24075305</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Body Composition ; Body Mass Index ; Chronic illnesses ; Chronic obstructive pulmonary disease ; Cohort Studies ; Comorbidity ; Confidence intervals ; Disease ; Female ; Follow-Up Studies ; Forced Expiratory Volume ; Functional capacity ; Humans ; Long-term follow-up ; Male ; Middle Aged ; Motor Activity ; Older people ; Participation ; Physical fitness ; Predictive Value of Tests ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Pulmonary Disease, Chronic Obstructive - therapy ; Pulmonary/Respiratory ; Rehabilitation ; Risk Factors ; Sensitivity and Specificity ; Six-min walk test ; Smoking - adverse effects ; Spirometry ; Surveys and Questionnaires ; Time Factors ; Vital Capacity ; Walking</subject><ispartof>Respiratory medicine, 2014-01, Vol.108 (1), p.86-94</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Jan 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c615t-1b7040b9578f142a4df87c14c6526a15e332b7bfbd9410ff002d105fb8b755b23</citedby><cites>FETCH-LOGICAL-c615t-1b7040b9578f142a4df87c14c6526a15e332b7bfbd9410ff002d105fb8b755b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rmed.2013.09.004$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,782,786,3552,27931,27932,46002</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24075305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Frisk, Bente</creatorcontrib><creatorcontrib>Espehaug, Birgitte</creatorcontrib><creatorcontrib>Hardie, Jon A</creatorcontrib><creatorcontrib>Strand, Liv I</creatorcontrib><creatorcontrib>Moe-Nilssen, Rolf</creatorcontrib><creatorcontrib>Eagan, Tomas M.L</creatorcontrib><creatorcontrib>Bakke, Per S</creatorcontrib><creatorcontrib>Thorsen, Einar</creatorcontrib><title>Physical activity and longitudinal change in 6-min walk distance in COPD patients</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><description>Summary Background The 6-min walk distance (6MWD) is widely used to evaluate functional capacity in patients with chronic obstructive pulmonary disease (COPD). Aim To examine predictors for longitudinal change in 6MWD including self-reported physical activity, smoking habits, body composition, exacerbations, comorbidity and lung function. Methods The cohort included 389 patients aged 44–75 years, with clinically stable COPD in GOLD stages II–IV. The follow-up time was 3 years. Measurements included 6MWD, spirometry, fat and fat free mass index (FMI and FFMI), and assessment of physical activity, smoking habits, comorbidities and exacerbations by questionnaires. Generalized estimating equations (GEE) regression analyses were used to analyze predictors for the change in 6MWD. Results There was a reduction in 6MWD from baseline to 3 years for patients in GOLD stages III and IV ( B  = −36 m, 95% CI = −51 to −7, p  = 0.009 and B  = −79 m, CI = −125 to −20, p  = 0.007). The unadjusted GEE analysis demonstrated that baseline self-reported physical activity level, forced expiratory volume in one second (FEV1 ), forced vital capacity, FFMI, GOLD stages and age predicted change in 6MWD, but in the adjusted GEE analysis only self-reported physical activity level ( p  = 0.001) and FEV1 ( p  = 0.019) predicted change over time. Conclusion Patients in GOLD stage II maintained their functional capacity assessed by 6MWD over 3 years, while it was significantly reduced for patients in GOLD stages III and IV. Level of physical activity and FEV1 were predictors for longitudinal change in functional capacity.</description><subject>Adult</subject><subject>Aged</subject><subject>Body Composition</subject><subject>Body Mass Index</subject><subject>Chronic illnesses</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Cohort Studies</subject><subject>Comorbidity</subject><subject>Confidence intervals</subject><subject>Disease</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Forced Expiratory Volume</subject><subject>Functional capacity</subject><subject>Humans</subject><subject>Long-term follow-up</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Motor Activity</subject><subject>Older people</subject><subject>Participation</subject><subject>Physical fitness</subject><subject>Predictive Value of Tests</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Pulmonary Disease, Chronic Obstructive - therapy</subject><subject>Pulmonary/Respiratory</subject><subject>Rehabilitation</subject><subject>Risk Factors</subject><subject>Sensitivity and Specificity</subject><subject>Six-min walk test</subject><subject>Smoking - adverse effects</subject><subject>Spirometry</subject><subject>Surveys and Questionnaires</subject><subject>Time Factors</subject><subject>Vital Capacity</subject><subject>Walking</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks1q3DAUhUVpaaZpX6CLYuimG7v36teGUijTXwgk9GctZFlONPHIU8lOmbfps_TJKmcSClk0K8G93zmgcy4hzxEqBJSvN1Xcuq6igKyCpgLgD8gKBaMlA8kfkhU0gpcSEY_Ik5Q2ANBwDo_JEeWgBAOxIl_PLvbJWzMUxk7-yk_7woSuGMZw7qe58yFv7IUJ567woZDl1oc_v3-Z4bLofJpMsNfz9enZ-2JnJu_ClJ6SR70Zknt28x6THx8_fF9_Lk9OP31ZvzsprUQxldgq4NA2QtU9cmp419fKIrdSUGlQOMZoq9q-7RqO0PcAtEMQfVu3SoiWsmPy6uC7i-PP2aVJb32ybhhMcOOcNNY1KsGVqO9HBXJOQQp2P8obqkBl74y-vINuxjnmxK4pZBwlE5miB8rGMaXoer2LfmviXiPopUe90UuPeulRQ6Nzj1n04sZ6bpfdreS2uAy8OQAuJ3zlXdTJ5vSt63x0dtLd6P_v__aO3A4-LHdw6fYu_fuHTlSD_rZc0nJIyACYbBT7CymVwLs</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Frisk, Bente</creator><creator>Espehaug, Birgitte</creator><creator>Hardie, Jon A</creator><creator>Strand, Liv I</creator><creator>Moe-Nilssen, Rolf</creator><creator>Eagan, Tomas M.L</creator><creator>Bakke, Per S</creator><creator>Thorsen, Einar</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>7TS</scope></search><sort><creationdate>20140101</creationdate><title>Physical activity and longitudinal change in 6-min walk distance in COPD patients</title><author>Frisk, Bente ; Espehaug, Birgitte ; Hardie, Jon A ; Strand, Liv I ; Moe-Nilssen, Rolf ; Eagan, Tomas M.L ; Bakke, Per S ; Thorsen, Einar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c615t-1b7040b9578f142a4df87c14c6526a15e332b7bfbd9410ff002d105fb8b755b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Body Composition</topic><topic>Body Mass Index</topic><topic>Chronic illnesses</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Cohort Studies</topic><topic>Comorbidity</topic><topic>Confidence intervals</topic><topic>Disease</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Forced Expiratory Volume</topic><topic>Functional capacity</topic><topic>Humans</topic><topic>Long-term follow-up</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Motor Activity</topic><topic>Older people</topic><topic>Participation</topic><topic>Physical fitness</topic><topic>Predictive Value of Tests</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Pulmonary Disease, Chronic Obstructive - therapy</topic><topic>Pulmonary/Respiratory</topic><topic>Rehabilitation</topic><topic>Risk Factors</topic><topic>Sensitivity and Specificity</topic><topic>Six-min walk test</topic><topic>Smoking - adverse effects</topic><topic>Spirometry</topic><topic>Surveys and Questionnaires</topic><topic>Time Factors</topic><topic>Vital Capacity</topic><topic>Walking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frisk, Bente</creatorcontrib><creatorcontrib>Espehaug, Birgitte</creatorcontrib><creatorcontrib>Hardie, Jon A</creatorcontrib><creatorcontrib>Strand, Liv I</creatorcontrib><creatorcontrib>Moe-Nilssen, Rolf</creatorcontrib><creatorcontrib>Eagan, Tomas M.L</creatorcontrib><creatorcontrib>Bakke, Per S</creatorcontrib><creatorcontrib>Thorsen, Einar</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Physical Education Index</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frisk, Bente</au><au>Espehaug, Birgitte</au><au>Hardie, Jon A</au><au>Strand, Liv I</au><au>Moe-Nilssen, Rolf</au><au>Eagan, Tomas M.L</au><au>Bakke, Per S</au><au>Thorsen, Einar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physical activity and longitudinal change in 6-min walk distance in COPD patients</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>108</volume><issue>1</issue><spage>86</spage><epage>94</epage><pages>86-94</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Summary Background The 6-min walk distance (6MWD) is widely used to evaluate functional capacity in patients with chronic obstructive pulmonary disease (COPD). Aim To examine predictors for longitudinal change in 6MWD including self-reported physical activity, smoking habits, body composition, exacerbations, comorbidity and lung function. Methods The cohort included 389 patients aged 44–75 years, with clinically stable COPD in GOLD stages II–IV. The follow-up time was 3 years. Measurements included 6MWD, spirometry, fat and fat free mass index (FMI and FFMI), and assessment of physical activity, smoking habits, comorbidities and exacerbations by questionnaires. Generalized estimating equations (GEE) regression analyses were used to analyze predictors for the change in 6MWD. Results There was a reduction in 6MWD from baseline to 3 years for patients in GOLD stages III and IV ( B  = −36 m, 95% CI = −51 to −7, p  = 0.009 and B  = −79 m, CI = −125 to −20, p  = 0.007). The unadjusted GEE analysis demonstrated that baseline self-reported physical activity level, forced expiratory volume in one second (FEV1 ), forced vital capacity, FFMI, GOLD stages and age predicted change in 6MWD, but in the adjusted GEE analysis only self-reported physical activity level ( p  = 0.001) and FEV1 ( p  = 0.019) predicted change over time. Conclusion Patients in GOLD stage II maintained their functional capacity assessed by 6MWD over 3 years, while it was significantly reduced for patients in GOLD stages III and IV. Level of physical activity and FEV1 were predictors for longitudinal change in functional capacity.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24075305</pmid><doi>10.1016/j.rmed.2013.09.004</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6111
ispartof Respiratory medicine, 2014-01, Vol.108 (1), p.86-94
issn 0954-6111
1532-3064
language eng
recordid cdi_proquest_miscellaneous_1881754758
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via ScienceDirect (Elsevier)
subjects Adult
Aged
Body Composition
Body Mass Index
Chronic illnesses
Chronic obstructive pulmonary disease
Cohort Studies
Comorbidity
Confidence intervals
Disease
Female
Follow-Up Studies
Forced Expiratory Volume
Functional capacity
Humans
Long-term follow-up
Male
Middle Aged
Motor Activity
Older people
Participation
Physical fitness
Predictive Value of Tests
Pulmonary Disease, Chronic Obstructive - physiopathology
Pulmonary Disease, Chronic Obstructive - therapy
Pulmonary/Respiratory
Rehabilitation
Risk Factors
Sensitivity and Specificity
Six-min walk test
Smoking - adverse effects
Spirometry
Surveys and Questionnaires
Time Factors
Vital Capacity
Walking
title Physical activity and longitudinal change in 6-min walk distance in COPD patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T04%3A21%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physical%20activity%20and%20longitudinal%20change%20in%206-min%C2%A0walk%20distance%20in%20COPD%20patients&rft.jtitle=Respiratory%20medicine&rft.au=Frisk,%20Bente&rft.date=2014-01-01&rft.volume=108&rft.issue=1&rft.spage=86&rft.epage=94&rft.pages=86-94&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2013.09.004&rft_dat=%3Cproquest_cross%3E1881754758%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1491341635&rft_id=info:pmid/24075305&rft_els_id=S0954611113003697&rfr_iscdi=true